Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AstraZeneca to Buy Respiratory Drug Company, Amirall | Contract Pharma

What are you searching for?

Sign in
Breaking News

AstraZeneca to Buy Respiratory Drug Company, Amirall

AZ will acquire the Catalan company, which specializes in drugs for COPD and other respiratory diseases

AstraZeneca has bought the Catalan company, Amirall’s, respiratory therapies business, including rights to Eklira, a drug that is designed to treat chronic obstructive pulmonary disease (COPD) and represents 14.4% of the company’s total sales. The Catalan News Agency reported this news on Wednesday, July 30, 2014.


AstraZeneca will reportedly pay $875 million initially, and up to $1.22 billion, depending on product development success, new product launches and sales.  “A significant number of employees” will reportedly be transferred to AstraZeneca, the news agency reported.   

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters